Metabolic disorders, such as phenylketonuria (PKU) and galactosemia, require early diagnosis through newborn screening programs. Treatment typically involves dietary management and enzyme replacement therapy. The effectiveness of these treatments largely depends on early detection and adherence to the prescribed regimen. With proper management, many infants with metabolic disorders can achieve normal growth and development.
